Research
Dalhousie researchers collaborate on greener sodium‑ion battery technology
Dalhousie researchers are working with Concordia's Volt-Age program to help advance sodium-ion battery technology — a more sustainable alternative to lithium for residential energy storage. Read more.
Featured News
Wednesday, June 10, 2026
A new Dalhousie University study suggests improved fitness may not be enough to protect blood vessels from the effects of prolonged sitting.
Thursday, June 11, 2026
Given increasing geopolitical tensions and economic interest in the region, how can academic research support those who live in and depend on the Arctic? Dal's Dr. Megan Bailey and colleagues consider.
Wednesday, February 25, 2026
Dalhousie is helping to prepare Canada’s defence community for AI-supported command and control, including fast developing Arctic surveillance scenarios, by simulating how humans and intelligent systems make decisions together under pressure.
Archives - Research
Wednesday, January 7, 2015
Recently named a prestigous Mayday Fellow, Dal nursing professor Marsha Campbell-Yeo has helped produce a new video for parents highlighting ways to safely and effectively reduce newborns' pain during medical and other procedures.
Tuesday, December 16, 2014
Alon Friendman, Dal's new William Dennis Chair in Epilepsy Research, is on the leading edge for early detection and diagnosis of damage to the brain's "shield" – the blood-brain barrier.
Monday, December 15, 2014
Dal Oceanography researcher Susanne Craig is the only Canadian selected for NASA's upcoming PACE satellite mission, which will examine connections between ocean ecology and climate change.
Friday, December 12, 2014
At this year's incarnation of the Dal Power breakfast series, leaders from different corners of the university discussed ways to help support entrepreneurship on campus.
Turning off the power: Dal scientist finds drug combination that stops growth of breast cancer cells
Friday, December 5, 2014
Dalhousie Medical School's Dr. Paola Marignani and her team have successfully tested a combination of drugs that shuts down aggressive HER2-positive breast cancers.